https://www.fiercebiotech.com/biote...stage-nash-drug-for-long-covid-phase-2a-trial
Here is a short quote: "Axcella Therapeutics, founded by the same incubator as Moderna, will test its midstage investigational drug for NASH in patients with muscle fatigue and weakness who have survived COVID-19. The biotech has teamed up with the University of Oxford for a phase 2a trial."
Here is a short quote: "Axcella Therapeutics, founded by the same incubator as Moderna, will test its midstage investigational drug for NASH in patients with muscle fatigue and weakness who have survived COVID-19. The biotech has teamed up with the University of Oxford for a phase 2a trial."